Document is current
Any future updates will be listed below
-
Authors
Deb-Chatterji, Milani http://orcid.org/0000-0003-4282-3518
Flottmann, Fabian
Meyer, Lukas
Brekenfeld, Caspar
Fiehler, Jens
Gerloff, Christian
Thomalla, Götz
,
Gerloff, C.
Fiehler, J.
Thomalla, G.
Alegiani, A.
Boeckh-Behrens,
Wunderlich, Silke
Ernemann, Ulrike
Poli, Sven
Siebert, Eberhard
Nolte, Christian H.
Zweynert, Sarah
Bohner, Georg
Ludolph, Alexander
Henn, Karl-Heinz
Schäfer, Jan Hendrik
Keil, Fee
Röther, Joachim
Eckert, Bernd
Berrouschot, Jörg
Bormann, Albrecht
Dorn, Franziska
Petzold, Gabor
Kraemer, Christoffer
Leischner, Hannes
Trumm, Christoph
Tiedt, Steffen
Kellert, Lars
Petersen, Martina
Stögbauer, Florian
Braun, Michael
Hamann, Gerhard F.
Gröschel, Klaus
Uphaus, Timo
Reich, Arno
Nikoubashman, Omid
Schellinger, Peter
Borggrefe, Jan
Hattingen, Jörg
Liman, Jan
Ernst, Marielle
- License Information
-
More Information
Article History
Received: 8 August 2022
Accepted: 12 October 2022
First Online: 21 November 2022
Declarations
:
: The study was approved by all responsible ethics committees of the participating sites. Written informed consent was obtained from the patient or their proxies. Consent was waived if patients died before consent could be obtained or lacked the capacity to give consent and no proxy was available.
: Not applicable.
: CB: The author declares that he has no competing interest. FF: received personal fees from Eppdata GmbH outside the submitted work. LM: received compensation as a speaker for Balt Prime outside the submitted work. MDC has received research grants from the Werner Otto Stiftung outside the submitted work. JF receives research support from the German Ministry of Science and Education (BMBF), German Ministry of Economy and Innovation (BMWi), German Research Foundation (DFG), European Union (EU), Hamburgische Investitions- und Förderbank (IFB), Medtronic, Microvention, Stryker; and serves as a consultant for Acandis, Cerenovus, Medtronic, Microvention, Penumbra, Phenox, and Stryker. CG serves on scientific advisory boards for Bayer Vital, Boehringer Ingelheim, Acticor Biotech, Amgen, and Prediction Biosciences; has received funding for travel and/or speaker/ consulting honoraria from Bayer Vital, Boehringer Ingelheim, Sanofi Aventis, Amgen, EBS Technologies, GlaxoSmithKline, Lundbeck, Pfizer, Silk Road Medical, and UCB, and Abbott; serves on editorial boards for INFO Neurologie & Psychiatrie and Aktuelle Neurologie and as editor of textbook Therapie und Verlauf neurologischer Erkrankungen; has received grants to supporting employees/ scientists of his clinic from Merz Pharmaceuticals, Allergan, Novartis, and NeuroConn; and receives research support from Deutsche Forschungsgesellschaft, the European Union, Wegener Foundation, Schilling Foundation, and Werner-Otto- Foundation. GT has received personal fees as consultant or lecturer from Acandis, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Daichi Sankyo, Stryker, and research grants from Bayer, Federal Ministry for Economic Affairs and Energy (BMWi), Corona-Foundation, German Research Foundation (DFG), Else Kröner-Fresenius Foundation, European Union (Horizon 2020), German Innovation Fund.
